Pharmaceutical economics & health policy - Editorial comment

被引：0

|

作者：

Sclar, DA

机构：

来源：

CLINICAL THERAPEUTICS | 1997年 / 19卷 / 03期

关键词：

D O I：

10.1016/S0149-2918(97)80138-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：538 / 539

页数：2

相关论文

共 50 条

[41] Pharmaceutical economics and policy.
Hicks, LL
INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 1998, 35 (01) : 91 - 91
[42] Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy? - Editorial comment
Lyles, Alan
CLINICAL THERAPEUTICS, 2007, 29 (09) : 2094 - 2095
[43] Use of patient-reported outcomes in pharmaceutical economics and health policy
Barr, Judith
CLINICAL THERAPEUTICS, 2006, 28 (10) : 1710 - 1711
[44] Showcasing Pharmaceutical Economics, Outcomes, and Health Policy: An Update in Clinical Therapeutics
Lau, Denys T.
CLINICAL THERAPEUTICS, 2013, 35 (04) : 354 - 355
[45] ECONOMICS IN THE POLICY PROCESS - A COMMENT
GOODE, R
NATIONAL TAX JOURNAL, 1994, 47 (02) : 403 - 405
[46] EDITORIAL POLICY STATEMENT - COMMENT
ALEIXANDRE, MPJ
SCIENCE EDUCATION, 1995, 79 (06) : 701 - 704
[47] Health Economics and Policy
Rawlings, Louise
Robson, Steve
ECONOMIC RECORD, 2019, 95 (308) : 173 - 176
[48] What does economics have to say about health policy anyway? Comment
Gaynor, M
Vogt, WB
JOURNAL OF HEALTH POLITICS POLICY AND LAW, 1997, 22 (02) : 475 - 496
[49] Health economics in the Canadian pharmaceutical industry
Assiff, L
Pollock, MR
Manzi, P
Faienza, B
Menon, D
PHARMACOECONOMICS, 1999, 16 (06) : 669 - 678
[50] Health Economics in the Canadian Pharmaceutical Industry
Lila Assiff
Michael R. Pollock
Patricia Manzi
Ben Faienza
Devidas Menon
PharmacoEconomics, 1999, 16 : 669 - 678

← 1 2 3 4 5 →